Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

OKUR

+ Watchlist+ Portfolio

OnKure Therapeutics, Inc.

Regulated industryPhysical productsSells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$2.58
52-Week Range
$2.01 – $5.38
Market Cap
$116.15M
P/E (TTM)
—
EPS (TTM)
-2.07
Dividend Yield
0.00%
Advanced Metrics
Price/Book
0.72
PEG Ratio
—
Return on Equity
-55.18%
Return on Assets
-34.38%
Gross Margin
0.00%
Operating Margin
0.00%
Profit Margin
0.00%
Current Ratio
18.84
Debt/Equity
0.01
Total Debt
$790.00K
Free Cash Flow
$-26.37M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$-48.30M

Market Snapshot

About

OnKure Therapeutics, Inc. is a precision oncology company developing targeted cancer therapies. The company focuses on novel small molecule inhibitors designed to address critical oncogenic drivers and resistance mechanisms in various tumor types.